Page 41 - Boxed Warning News Today

/PRNewswire/ -- Neurelis and Little Angels Service Dogs are proud to present the "Barks n Blues Music & More" concert for epilepsy awareness at the Quartyard,...

 SAN DIEGO, Aug. 19, 2022 /PRNewswire/ -- Neurelis and Little Angels Service Dogs are proud to present the Barks n Blues Music & More concert f...

/PRNewswire/ -- Tris Pharma, Inc. ("Tris") a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today the decision by...

/PRNewswire/ -- Neurelis, Inc., is pleased to announce it has been named one of the Best Places to Work in SoCal 2022 by Best Companies Group (BCG), a...

/PRNewswire/ -- Neurelis, Inc., is pleased to announce it has been named one of the Best Places to Work in SoCal 2022 by Best Companies Group (BCG), a...

17.08.2022 - Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced the U.S. Food and Drug Administration (FDA) has approved the citrate-free, high-concentration (100 mg/mL) formulation of HADLIMA (adalimumab-bwwd), a biosimilar referencing ...

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) agreed to acquire remaining worldwide rights of Trodelvy. Gilead will assume responsibility for clinical development and commercialization in

/PRNewswire/ -- Tris Pharma, Inc. (Tris) a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today that DYANAVEL® XR...

- ZYNRELEF® launch trend continues at a strong pace with sequential quarterly product sales increase of 140% and unit demand increase of 47% - - Oncology Care...

/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and...